Introduction: Clerodendron infortunatum Linn.
INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder of carbohydrate, lipid, and protein metabolism.
It is characterized by hyperglycemia, glycosurea, hyperlipidemia, negative nitrogen balance, and sometimes ketonemia, due to insufficient or complete cessation of insulin synthesis, or secretion and/or peripheral resistance to insulin action. Diabetes is still not completely curable by current antidiabetic drugs. Insulin therapy is the only satisfactory approach in diabetes mellitus, even though it has several drawbacks, such as insulin resistance, anorexia, brain atrophy, and fatty liver, in chronic treatment. 1 Treatment of patients with type 2 diabetes mellitus with oral hypoglycemic agents like sulfonylureas and biguanides, is always associated with side effects. 2 Therefore, herbal drugs are gaining popularity in the treatment of diabetes mellitus.
The main benefits of herbal medicine seem to be their efficacy, low incidence of adverse effects, and low cost.
C l e r o d e n d r o n i n f o r t u n a t u m L i n n . (Verbenaceae), commonly known as Bhant in
Hindi, is a small shrub occurring throughout the plains of India. This plant has been used in Indian folk medicine in the treatment of bronchitis, asthma, fever, burning sensation, diseases of the blood, inflammation, and epilepsy. 3, 4 Traditionally, the plant is used as an antipyretic and anthelmintic. Leaves of the plant are prescribed for tumors, certain skin diseases, and scorpion stings. 5 Previous phytochemical investigation of the plant revealed the presence of alkyl sterols and 2,-(3,4-dehydroxyphenyl)
(4-O-caffeoyl) glycopyranoside or acteoside. 6, 7 Previous work has reported hepatoprotective, anti-inflammatory, antinociceptive, and neuropharmacological activities of C.
infortunatum. [8] [9] [10] 
MATERIALS AND METHODS

Plant Material
The leaves of C. infortunatum were collected The leaves were dried under shade and then powdered using a mechanical grinder into a coarse powder.
Preparation of Extract
The powdered plant material was extracted with 80% methanol using Soxhlet extraction apparatus. 
Treatment Schedule and Estimation of Fasting Blood Glucose Level
The rats were divided into five groups (n=6). The rats were then killed by cervical dislocation for the study of liver biochemical parameters.
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Estimation of Serum Biochemical Parameters
Collected blood was used for the estimation of serum biochemical parameters viz. serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), serum alkaline phosphatase (SALP), serum cholesterol, and total protein contents by using commercially available reagent kits (Span Diagnostics, Surat, India).
Estimation of Liver Biochemical Parameters
Lipid peroxidation, ie, thiobarbituric acid reactive substances (TBARS), was estimated by a previously reported method and expressed as millimoles per 100 g of tissue.
14 GSH was determined by a previously reported method and was expressed as milligrams per 100 g of tissue.
15 Catalase (CAT) activity was assayed according to the method described earlier, and expressed as micromoles of hydrogen peroxide (H 2 O 2 ) consumed per minute per milligram of liver tissue.
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Statistical Analysis
The experimental results were expressed as mean ± standard error of mean (SEM were considered to be statistically significant.
RESULTS
Fasting Blood Glucose
The fasting blood glucose levels of normal, diabetic, and treated rats are summarized in Table 1 . STZ at the dose of 65 mg/kg produced marked hyperglycemia as evident from a significant (P<0.001) elevation in fasting blood glucose level in the STZ control group as compared to the normal control group.
Administration of MECI in STZ-induced diabetic rats at the doses of 250 and 500 mg/kg b.w.
produced a significant (P<0.001) and dosedependent decrease in blood glucose levels when compared with the STZ control group.
Body Weight
The body weight of rats from the STZ control group (after 15 days) was significantly (P<0.001) decreased when compared with the normal control group. MECI at 250 and 500 mg/kg b.w.
significantly (P<0.001) increased body weight towards normal levels in a dose-dependent manner compared to the STZ control group (Table 2) .
Serum Biochemical Parameters
Biochemical (Table 3) .
Liver Biochemical Parameters
The levels of TBARS were significantly (P<0.001) increased in STZ control animals as compared to (Table 4) .
DISCUSSION
The present work was intended to study there is an increase in total cholesterol present in blood, which may contribute to coronary artery diseases. 22 In the present study, the elevated serum cholesterol levels in diabetic rats was normalized after treatment with MECI. This suggests that the extract may inhibit the pathway of cholesterol synthesis in diabetic rats.
Oxidative stress in diabetes mellitus has been shown to coexist with a reduction in the endogenous antioxidant status. 23 Several sources 
